Business Card for Charles Lynn:

Global Sourcing Manager, Compliance and ...
Chicago, IL area
Email Avail: 3 Day Free Trial

275 N Field Dr
Lake Forest, IL 60045

Tel: (224) 212-2000

Last updated on 2018-03-24

About Charles Lynn:

Charles Lynn works as an Global Sourcing Manager, Compliance and ... for Hospira at Chicago, IL. The company's webpage is For email, phone number and executive profiles for Global Sourcing Manager, Compliance and ... and other executives of Hospira at Chicago, IL, check Hospira at Not the Charles Lynn you are looking for? Do a quick search in our website and find other people named Charles Lynn.
Charles Lynn's Work History:
SR Quality Engineer at Tornier
SR Quality Engineer at Integra LifeSciences
Quality Engineer at Pole/Zero Corporation
Director of Quality and Risk Management at Sekuworks
Quality Manager at Sekuworks
SR Quality Engineer at Covidien
Quality Engineer at Covidien ( formerly Tyco Healthcare/Malinckrodt/Liebel-Flarsheim)
Quality Engineer at Rand McNally - Docusystems
Quality Engineer at Multi-Color Corporation.

Charles Lynn's Education:
Miami University
Indiana University Bloomington.

Charles Lynn's Co-workers:
As of July 2, 2020, Charles Lynn has 366 co-workers under the company name Hospira at

About Hospira:

Hospira, Inc. (Hospira) is a provider of injectable drugs and infusion technologies. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira's portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira conducts operations worldwide and is managed in three reportable segments: Americas; Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa, and the APAC segment includes Asia, Japan, Australia and New Zealand. In all segments, Hospira sells a line of prod...... (Source: SEC reports)

Company News:
No company news available.